Your browser doesn't support javascript.
loading
HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer.
Cabel, L; Bonneau, C; Bernard-Tessier, A; Héquet, D; Tran-Perennou, C; Bataillon, G; Rouzier, R; Féron, J-G; Fourchotte, V; Le Brun, J-F; Benoît, C; Rodrigues, M; Scher, N; Minsat, M; Legrier, M-E; Bièche, I; Proudhon, C; Sastre-Garau, X; Bidard, F-C; Jeannot, E.
Affiliation
  • Cabel L; Department of Medical Oncology, Institut Curie, Paris and Saint Cloud, France.
  • Bonneau C; UVSQ, Paris-Saclay University, Gif-sur-Yvette, France; Department of Surgical Oncology, Institut Curie, Saint Cloud, France.
  • Bernard-Tessier A; Department of Pathology and Genetics, Institut Curie, Paris and Saint Cloud, France.
  • Héquet D; Department of Surgical Oncology, Institut Curie, Saint Cloud, France; U900, UVSQ, Paris-Saclay University, Gif-sur-Yvette, France.
  • Tran-Perennou C; Department of Pathology and Genetics, Institut Curie, Paris and Saint Cloud, France.
  • Bataillon G; Department of Pathology and Genetics, Institut Curie, Paris and Saint Cloud, France.
  • Rouzier R; Department of Surgical Oncology, Institut Curie, Saint Cloud, France; U900, UVSQ, Paris-Saclay University, Gif-sur-Yvette, France.
  • Féron JG; Department of Surgical Oncology, Institut Curie, Saint Cloud, France.
  • Fourchotte V; Department of Surgical Oncology, Institut Curie, Saint Cloud, France.
  • Le Brun JF; Department of Gynecology and Obstetrics, CCC François Baclesse, Caen, France.
  • Benoît C; Department of Radiation Oncology, Centre Jean Perrin, Clermont-Ferrand, France.
  • Rodrigues M; Department of Medical Oncology, Institut Curie, Paris and Saint Cloud, France.
  • Scher N; Department of Radiation Oncology, Institut Curie, Paris and Saint Cloud, France.
  • Minsat M; Department of Radiation Oncology, Institut Curie, Paris and Saint Cloud, France.
  • Legrier ME; Department of Research, Institut Curie, Paris and Saint Cloud, France.
  • Bièche I; Department of Pathology and Genetics, Institut Curie, Paris and Saint Cloud, France; Paris University, Paris, France.
  • Proudhon C; Circulating Tumor Biomarkers Laboratory, Institut Curie, Paris, France.
  • Sastre-Garau X; Department of Pathology, Hôpital Intercommunal de Créteil, Créteil, France.
  • Bidard FC; Department of Medical Oncology, Institut Curie, Paris and Saint Cloud, France; UVSQ, Paris-Saclay University, Gif-sur-Yvette, France; Circulating Tumor Biomarkers Laboratory, Institut Curie, Paris, France.
  • Jeannot E; Department of Pathology and Genetics, Institut Curie, Paris and Saint Cloud, France. Electronic address: emmanuelle.jeannot@curie.fr.
ESMO Open ; 6(3): 100154, 2021 06.
Article in En | MEDLINE | ID: mdl-34022731
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Neoplasms / Papillomavirus Infections / Alphapapillomavirus / Circulating Tumor DNA Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: ESMO Open Year: 2021 Document type: Article Affiliation country: Francia Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Neoplasms / Papillomavirus Infections / Alphapapillomavirus / Circulating Tumor DNA Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: ESMO Open Year: 2021 Document type: Article Affiliation country: Francia Country of publication: Reino Unido